Panagiotis Konstantinopoulos

33PUBLICATIONS
195CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jul 30, 2026
Transcriptional signatures indicating RB function correlate with response to CDK4/6 inhibition in endometrial cancer.

|May 04, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.

|Mar 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial.

Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir

|Dec 03, 2025
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial.

Panagiotis A Konstantinopoulos, Ningxuan Zhou, Richard T Penson

|Sep 04, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder

|Aug 27, 2025
PIK3CB Inhibitor GSK2636771 in Cancers With PTEN Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and P.

Filip Janku, Opeyemi A Jegede, Shannon L Puhalla

Pageof 6

Frequent Collaborators

8 joint publications

Madeline Polak

8 joint publications

Ursula A Matulonis

7 joint publications

Elizabeth K Lee

6 joint publications

Alan D D'Andrea